Barinthus Biotherapeutics

NASDAQ: BRNS · Real-Time Price · USD
1.26
-0.02 (-1.25%)
At close: Aug 15, 2025, 3:59 PM
1.33
5.97%
Pre-market: Aug 18, 2025, 07:10 AM EDT

Barinthus Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-61.18M -73.63M 5.32M -51.11M
Depreciation & Amortization
5.8M n/a 4.32M 602K
Stock-Based Compensation
4.71M 5.05M 9.88M 16.49M
Other Working Capital
1.7M 3.88M -183K -63K
Other Non-Cash Items
19.18M 14.57M -24.09M 8.74M
Deferred Income Tax
-44K -3.09M -4.34M -119K
Change in Working Capital
2.6M 6.17M -5.52M -7.18M
Operating Cash Flow
-28.94M -50.92M -14.43M -32.58M
Capital Expenditures
-892K -5.41M -6.14M -1.15M
Cash Acquisitions
n/a n/a 387.76K -11.77M
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a -5.41M 240.00 n/a
Investing Cash Flow
-892K -5.41M -5.75M -12.91M
Debt Repayment
n/a n/a -159K n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a -163K n/a -5.27M
Financial Cash Flow
2.16M 1.87M 325K 222.74M
Net Cash Flow
-29.69M -52.3M -19.67M 170.79M
Free Cash Flow
-29.83M -56.34M -20.57M -33.73M